Private company

SciClone Pharmaceuticals (United States)

SciClone Pharmaceuticals (United States) is an American pharmaceutical preparations company, incorporated in Delaware.¹ It is headquartered in Foster City, California.¹

Last updated Oct 20, 2026.

Overview

1989Founded¹

IndustryPharmaceutical Preparations¹
HeadquartersFoster City, California¹
Websitewww.sciclone.com
Incorporated inDE³
Business address950 Tower Lane, Suite 900, Foster City, Ca 94404-2125³
Filer categoryAccelerated filer³

See how the biggest companies compare on our leaderboards

What it owns

What SciClone Pharmaceuticals (United States) reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Item	Latest	A year before	Change
Property and equipment, before depreciation	$7.2M⁴ Dec 31, 2016	$6.8M⁴ Dec 31, 2015	+6.1%
Accumulated depreciation	$5.2M⁴ Dec 31, 2016	$4.2M⁴ Dec 31, 2015	+25.6%
Property and equipment, net	$2.0M⁴ Dec 31, 2016	$2.7M⁴ Dec 31, 2015	−24.5%

Investments

Item	Latest	A year before	Change
Cash and cash equivalents	$134.4M⁴ Dec 31, 2016	$101.4M⁴ Dec 31, 2015	+32.5%

Intangibles and goodwill

Item	Latest	A year before	Change
Goodwill	$30.8M⁴ Dec 31, 2016	$33.0M⁴ Dec 31, 2015	−6.5%

Inventory

Item	Latest	A year before	Change
Inventory, total	$16.6M⁴ Dec 31, 2016	$11.0M⁴ Dec 31, 2015	+51.1%
Raw materials	$5.3M⁴ Dec 31, 2016	$3.9M⁴ Dec 31, 2015	+37.0%
Work in process	$498.0K⁴ Dec 31, 2016	$535.0K⁴ Dec 31, 2015	−6.9%
Finished goods	$10.8M⁴ Dec 31, 2016	$6.6M⁴ Dec 31, 2015	+64.2%

Leadership

Who has led SciClone Pharmaceuticals (United States), and when. Pick a name to see everywhere that person has worked.

Chief executive

President

Friedhelm Blobel2006–2017

Chief financial officer

Chief operating officer

19901995200020052010201520202025

Chief executive officerMark Lotter Apr 21, 2011 to Apr 4, 2012⁵
Chief executive officerFriedhelm Blobel Jun 2, 2006 to Oct 16, 2017⁶
PresidentFriedhelm Blobel Jun 2, 2006 to Oct 16, 2017⁶
Chief financial officerWilson Wai-Shun Cheung Jul 22, 2013 to Oct 16, 2017⁷
Chief financial officerLan Xie Aug 10, 2012 to Oct 16, 2017⁸
Chief financial officerGary Titus Dec 10, 2008 to Jun 18, 2012⁹
Chief financial officerRichard A. Waldron Feb 27, 2006 to Mar 22, 2007¹⁰
Chief operating officerJie Jackie Guan Jun 19, 2012 to Jun 19, 2012¹¹
Chief operating officerAlfred R. Rudolph Feb 27, 2006 to Feb 27, 2006¹²

Board members and other officers (23)

Gen. Counsel & VP ComplianceChuncai Meng Feb 19, 2014 to Aug 16, 2016¹³
VP, Finance & ControllerRaymond Anthony Low Oct 16, 2013 to Oct 16, 2017¹⁴
OfficerMin Yin Jun 14, 2012 to Mar 18, 2014¹⁵
VP, Finance and ControllerStephanie Wong Aug 10, 2012 to Apr 8, 2013¹⁶
Chief Medical OfficerIsrael Rios May 19, 2009 to Apr 4, 2012¹⁷
Principal Accounting OfficerIvan Hui Mar 22, 2007 to May 22, 2009¹⁸
Managing Dir., SciClone Int'lHans P. Schmid Feb 27, 2006 to May 17, 2010¹⁹
Board memberRaymond Anthony Low Oct 16, 2017 to Oct 16, 2017²⁰
Board memberSimon Li Feb 21, 2013 to Oct 16, 2017²¹
Board memberNancy T. Chang Sep 19, 2013 to Oct 16, 2017²²
Board memberPeter Barrett Apr 20, 2011 to Jun 11, 2012²³
Board memberMark Lotter Apr 21, 2011 to Apr 21, 2011⁵
Board memberGregg Anthony Lapointe Apr 1, 2009 to Oct 16, 2017²⁴
Board memberRoberto Camerini Apr 1, 2009 to Jun 16, 2011²⁵
Board memberTrevor M. Jones Apr 1, 2009 to Jul 5, 2011²⁶
Board memberFriedhelm Blobel Jun 2, 2006 to Oct 16, 2017⁶
Board memberDean S. Woodman Jun 15, 2006 to May 24, 2011²⁷
Board memberJohn D. Baxter Jun 15, 2006 to May 22, 2009²⁸
Board memberJon S. Saxe Jun 15, 2006 to Oct 16, 2017²⁹
Board memberRichard J. Hawkins Jun 15, 2006 to Oct 16, 2017³⁰
Board memberRolf H. Henel Jun 15, 2006 to May 18, 2009³¹
Board memberIra D. Lawrence Jun 16, 2006 to Jun 8, 2012³²
General counselCarey Chern Nov 15, 2016 to Oct 16, 2017³³

Timeline

Apr 21, 2011New chief executive Mark Lotter becomes CEO⁵
Jun 2, 2006New chief executive Friedhelm Blobel becomes CEO⁶
1989Founded Founded¹

SEC filer profile

How SciClone Pharmaceuticals (United States) is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARSCICLONE PHARMACEUTICALS INC²
CIK0000880771
Employer ID (EIN)94-3116852²
Filer statusAccelerated filer²
Incorporated inDelaware²
Fiscal year endsDecember 31²
Industry code (SIC)2834 Pharmaceutical Preparations²
Business address950 Tower Lane, Suite 900, Foster City, CA 94404-2125²
Phone650-358-3456²
Shares outstanding52,191,854 as of Aug 3, 2017³⁴
Public float$670.2M as of Jun 30, 2016⁴
On EDGAR sinceFeb 14, 1994²
Filings1,049 in all: 4 (450), 8-K (167), 10-Q (65), SC 13G/A (39), 3 (33), DEFA14A (26), DEF 14A (22), SC 13G (22)²
All 47 form types
SC 13D/A (21), 10-K (17), CORRESP (15), EFFECT (15), S-3 (15), S-8 POS (13), POS AM (12), S-8 (12), UPLOAD (12), S-3/A (10), CT ORDER (9), 10-Q/A (7), 4/A (7), SC 13D (7), 10-K/A (6), 8-K/A (6), ARS (5), 10-K405 (4), 424B3 (3), NT 10-K (3), PRE 14A (3), S-2/A (3), 424B2 (2), 8-A12G (2), NO ACT (2), 15-12G (1), 25-NSE (1), 3/A (1), 424B4 (1), 424B7 (1), 5 (1), 8-A12G/A (1), DEFM14A (1), DEFR14A (1), DFAN14A (1), NT 10-Q (1), PREM14A (1), RW (1), S-2 (1)
Latest filingsAnnual report (10-K) Mar 9, 2017
Quarterly report (10-Q) Aug 9, 2017
Proxy statement (DEF 14A) Apr 28, 2017
Latest 8-K (8-K) Oct 13, 2017

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataSciClone Pharmaceuticals (United States) on Wikidata
2
SEC EDGARSciClone Pharmaceuticals (United States) filings on SEC EDGAR
3
SEC EDGARSciClone Pharmaceuticals (United States) filings on SEC EDGAR
4
SEC EDGARSciClone Pharmaceuticals (United States) 10-K for fiscal 2016
5
SEC EDGARMark Lotter, Chief executive officer
6
SEC EDGARFriedhelm Blobel, Chief executive officer
7
SEC EDGARWilson Wai-Shun Cheung, Chief financial officer
8
SEC EDGARLan Xie, Chief financial officer
9
SEC EDGARGary Titus, Chief financial officer
10
SEC EDGARRichard A. Waldron, Chief financial officer
11
SEC EDGARJie Jackie Guan, Chief operating officer
12
SEC EDGARAlfred R. Rudolph, Chief operating officer
13
SEC EDGARChuncai Meng, Gen. Counsel & VP Compliance
14
SEC EDGARRaymond Anthony Low, VP, Finance & Controller
15
SEC EDGARMin Yin, Officer
16
SEC EDGARStephanie Wong, VP, Finance and Controller
17
SEC EDGARIsrael Rios, Chief Medical Officer
18
SEC EDGARIvan Hui, Principal Accounting Officer
19
SEC EDGARHans P. Schmid, Managing Dir., SciClone Int'l
20
SEC EDGARRaymond Anthony Low, Board member
21
SEC EDGARSimon Li, Board member
22
SEC EDGARNancy T. Chang, Board member
23
SEC EDGARPeter Barrett, Board member
24
SEC EDGARGregg Anthony Lapointe, Board member
25
SEC EDGARRoberto Camerini, Board member
26
SEC EDGARTrevor M. Jones, Board member
27
SEC EDGARDean S. Woodman, Board member
28
SEC EDGARJohn D. Baxter, Board member
29
SEC EDGARJon S. Saxe, Board member
30
SEC EDGARRichard J. Hawkins, Board member
31
SEC EDGARRolf H. Henel, Board member
32
SEC EDGARIra D. Lawrence, Board member
33
SEC EDGARCarey Chern, General counsel
34
SEC EDGARSciClone Pharmaceuticals (United States) 10-Q filed Aug 9, 2017: shares outstanding